The settlements resolve a long-running criminal probe of the generic pharmaceutical industry dating to 2014.
Five other companies, including Novartis-owned Sandoz, have entered into deferred prosecution agreements and paid $426 million in criminal fines.
A senior sales executive from Taro Pharmaceuticals is fighting price-fixing charges stemming from the same investigation. Glenmark was indicted in July 2020 in Philadelphia federal court, with Teva added to the indictment the following month. Teva, Glenmark and Apotex, which agreed to a criminal fine of $24 million, were charged with conspiring to fix prices of pravastatin.
Other charges against Teva included conspiring with Taro to fix prices of drugs including treatments for seizures and bipolar disorder, arthritis, eczema and blood clots; and conspiring with Sandoz to fix prices on treatments for arthritis, high blood pressure, brain cancer and cystic fibrosis. While Teva was the last and largest of the generic drugmakers to face charges, myriad companies face civil claims in a variety of class-action lawsuits and cases brought by nearly every state attorney general in the country.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Twitter erases photos from 2011-2014, users panicThe links that used Twitter’s URL shortener are also broken.
Read more »
Teva to pay $225 million in fines and divest generic drug to resolve price-fixing chargesIt's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product.
Read more »
Hilariously Generic Action Abounds in First Trailer for John Cena, Allison Brie's FreelanceFreelance looks roughly like what you'd get by blending up last year's The Lost City with John Cena's own The Marine from 2006.
Read more »